Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of bile acid activated receptors hybrid molecules for the treatment of inflammatory and metabolic disorders. | Biochem Pharmacol | 2023 | 37659739 | PubTator, text mining | PubMed |
| Diagnostic accuracy of biomarkers to detect acute mesenteric ischaemia in adult patients: a systematic review and meta-analysis. | World J Emerg Surg | 2023 | 37658356 | PubTator, text mining | PubMed |
| No impact of a high-fat meal coupled with intermittent hypoxemia on acute kidney injury biomarkers in adults with and without obstructive sleep apnea. | Physiol Rep | 2023 | 37653582 | PubTator, text mining | PubMed |
| Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD. | Int J Mol Sci | 2023 | 37628929 | PubTator, text mining | PubMed |
| Using Hepatic Gene Expression Assays in English Sole (Parophrys vetulus) to Investigate the Effects of Metro Vancouver Wastewater Effluents. | Toxics | 2023 | 37624162 | PubTator, text mining | PubMed |
| Hepatic adenoma in a 7-year-old girl: a case report and literature review. | BMC Pediatr | 2023 | 37620840 | PubTator, text mining | PubMed |
| Lipid oxidation dysregulation: an emerging player in the pathophysiology of sepsis. | Front Immunol | 2023 | 37600769 | PubTator, text mining | PubMed |
| Transient naive reprogramming corrects hiPS cells functionally and epigenetically. | Nature | 2023 | 37587336 | PubTator, text mining | PubMed |
| F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit. | World J Gastroenterol | 2023 | 37576703 | PubTator, text mining | PubMed |
| Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin. | Int J Mol Sci | 2023 | 37569847 | PubTator, text mining | PubMed |
| Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease. | Animal Model Exp Med | 2023 | 37565549 | PubTator, text mining | PubMed |
| Diagnostic challenges of diabetic kidney disease. | Biochem Med (Zagreb) | 2023 | 37545693 | PubTator, text mining | PubMed |
| Biomarkers in Duchenne Muscular Dystrophy: Current Status and Future Directions. | J Neuromuscul Dis | 2023 | 37545256 | PubTator, text mining | PubMed |
| Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse. | J Transl Med | 2023 | 37543577 | PubTator, text mining | PubMed |
| Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway. | Front Pharmacol | 2023 | 37538178 | PubTator, text mining | PubMed |
| Distinct associations between dietary omega-3 and omega-6 fatty acids intake with chronic kidney disease in adults with and without diabetes: A cross-sectional study. | Nutrition | 2023 | 37536024 | PubTator, text mining | PubMed |
| Development of Plasmodium falciparum liver-stages in hepatocytes derived from human fetal liver organoid cultures. | Nat Commun | 2023 | 37532704 | PubTator, text mining | PubMed |
| Cardiorenal Syndrome: A Literature Review. | Cureus | 2023 | 37529809 | PubTator, text mining | PubMed |
| Disclosing Environmental Ligands of L-FABP and PPARγ: Should We Re-evaluate the Chemical Safety of Hydrocarbon Surfactants? | Environ Sci Technol | 2023 | 37527448 | PubTator, text mining | PubMed |
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR). | Cardiovasc Diabetol | 2023 | 37525257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=20